Peter Riederer
Impact in
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
Papers in
- Neurology 79
- Parkinson's Disease Mechanisms and Treatments 69
- Neurological disorders and treatments 37
- Neurological diseases and metabolism 10
-
- Neuroscience and Neuropharmacology Research 23
- Neurotransmitter Receptor Influence on Behavior 15
- Co-authors
- Moussa B. H. Youdim (20 shared papers)W Birkmayer (22 shared papers)St. Wuketich (4 shared papers)K. A. Jellinger (24 shared papers)Toshiharu Nagatsu (6 shared papers)M. Gerlach (12 shared papers)Masayasu Minami (1 shared paper)Minoru Harada (1 shared paper)
In The Last Decade
Peter Riederer
197 papers receiving 8.6k citations
Peter Riederer's Hit Papers
Peers
Comparison fields: 5 of 173
- Neurology 3.6k
- Biological Psychiatry 470
- Neurology 1.3k
- Cellular and Molecular Neuroscience 2.6k
- Clinical Biochemistry 505
Countries citing papers authored by Peter Riederer
This map shows the geographic impact of Peter Riederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Riederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Riederer more than expected).
Fields of papers citing papers by Peter Riederer
This network shows the impact of papers produced by Peter Riederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Riederer. The network helps show where Peter Riederer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Riederer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients Hit paper breakdown → | 1994 | 703 |
| 2 | 1976 | 451 | |
| 3 | 1985 | 332 | |
| 4 | 2004 | 297 | |
| 5 | 2004 | 288 | |
| 6 | 1997 | 279 | |
| 7 | 2005 | 273 | |
| 8 | 1977 | 225 | |
| 9 | 2012 | 219 | |
| 10 | 2001 | 202 | |
| 11 | 1986 | 201 | |
| 12 | 2008 | 192 | |
| 13 | 2007 | 179 | |
| 14 | 2005 | 176 | |
| 15 | 1995 | 141 | |
| 16 | 2006 | 136 | |
| 17 | 1990 | 117 | |
| 18 | 1997 | 110 | |
| 19 | 1978 | 102 | |
| 20 | 2001 | 100 |
About Peter Riederer
Peter Riederer is a scholar working on Neurology, Cellular and Molecular Neuroscience, Physiology, Molecular Biology and Pharmacology, having authored 200 papers that have together received 8.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (69 papers), Neurological disorders and treatments (37 papers), Neuroscience and Neuropharmacology Research (23 papers), Alzheimer's disease research and treatments (22 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Building Energy and Comfort Optimization (14 papers), Neurological diseases and metabolism (10 papers) and Tryptophan and brain disorders (10 papers). The work is most often cited by research in Neurology (3.6k citations), Biological Psychiatry (470 citations), Neurology (1.3k citations), Cellular and Molecular Neuroscience (2.6k citations) and Clinical Biochemistry (505 citations). Peter Riederer has collaborated with scholars based in Germany, Austria and Denmark. Frequent co-authors include Moussa B. H. Youdim, W Birkmayer, St. Wuketich, K. A. Jellinger, Toshiharu Nagatsu, M. Gerlach, Masayasu Minami, Minoru Harada, Makio Mogi and Hirofumi Inagaki. Their work appears in journals such as Journal of Neural Transmission, Pharmacopsychiatry, Energy and Buildings, Cells and Neurotoxicity Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.